Gilead Sciences (GILD) Inventory Average (2009 - 2026)

Gilead Sciences (GILD) has reported Inventory Average for 18 consecutive years, with $1.8 billion the latest figure, recorded in Q1 2026.

• Inventory Average for Q1 2026 came in at $1.8 billion, up 6.31% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.8 billion (up 6.31% YoY), and the FY2025 annual result was $1.7 billion, changed 0.37% from the prior year.
• Inventory Average was $1.8 billion for Q1 2026 at Gilead Sciences, up from $1.8 billion in the prior quarter.
• Over five years, Inventory Average peaked at $1.9 billion in Q3 2024 and troughed at $1.5 billion in Q3 2022.
• Average Inventory Average over 5 years is $1.7 billion, with a median of $1.7 billion recorded in 2025.
• Year-over-year, Inventory Average fell 16.19% in 2022 and rose 20.88% in 2024.
• Over 5 years, Inventory Average stood at $1.5 billion in 2022, then advanced by 16.16% to $1.7 billion in 2023, then gained by 3.74% to $1.8 billion in 2024, then slipped by 0.56% to $1.8 billion in 2025, then grew by 3.62% to $1.8 billion in 2026.
• Per Business Quant data, the three most recent Inventory Average figures were $1.8 billion in Q1 2026, $1.8 billion in Q4 2025, and $1.8 billion in Q3 2025.